nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP1A2—Carmustine—lymphatic system cancer	0.188	0.273	CbGbCtD
Almotriptan—CYP2E1—Mitoxantrone—lymphatic system cancer	0.153	0.222	CbGbCtD
Almotriptan—CYP2C19—Teniposide—lymphatic system cancer	0.137	0.199	CbGbCtD
Almotriptan—CYP3A4—Cytarabine—lymphatic system cancer	0.0673	0.0975	CbGbCtD
Almotriptan—CYP3A4—Teniposide—lymphatic system cancer	0.0663	0.096	CbGbCtD
Almotriptan—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0464	0.0672	CbGbCtD
Almotriptan—CYP3A4—Vincristine—lymphatic system cancer	0.0319	0.0462	CbGbCtD
Almotriptan—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00149	0.00481	CcSEcCtD
Almotriptan—Agitation—Fludarabine—lymphatic system cancer	0.00149	0.0048	CcSEcCtD
Almotriptan—Tachycardia—Teniposide—lymphatic system cancer	0.00147	0.00474	CcSEcCtD
Almotriptan—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00146	0.00471	CcSEcCtD
Almotriptan—Malaise—Fludarabine—lymphatic system cancer	0.00146	0.00471	CcSEcCtD
Almotriptan—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00145	0.00469	CcSEcCtD
Almotriptan—Muscular weakness—Vincristine—lymphatic system cancer	0.00145	0.00467	CcSEcCtD
Almotriptan—Pruritus—Mechlorethamine—lymphatic system cancer	0.00144	0.00466	CcSEcCtD
Almotriptan—Convulsion—Fludarabine—lymphatic system cancer	0.0014	0.00453	CcSEcCtD
Almotriptan—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00139	0.0045	CcSEcCtD
Almotriptan—Myalgia—Fludarabine—lymphatic system cancer	0.00138	0.00445	CcSEcCtD
Almotriptan—Arthralgia—Fludarabine—lymphatic system cancer	0.00138	0.00445	CcSEcCtD
Almotriptan—Discomfort—Fludarabine—lymphatic system cancer	0.00136	0.00439	CcSEcCtD
Almotriptan—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00135	0.00438	CcSEcCtD
Almotriptan—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00134	0.00435	CcSEcCtD
Almotriptan—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00134	0.00433	CcSEcCtD
Almotriptan—Dyspnoea—Teniposide—lymphatic system cancer	0.00134	0.00433	CcSEcCtD
Almotriptan—Confusional state—Fludarabine—lymphatic system cancer	0.00133	0.0043	CcSEcCtD
Almotriptan—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00132	0.00426	CcSEcCtD
Almotriptan—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.0013	0.00419	CcSEcCtD
Almotriptan—Vomiting—Mechlorethamine—lymphatic system cancer	0.00129	0.00418	CcSEcCtD
Almotriptan—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00129	0.00418	CcSEcCtD
Almotriptan—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00129	0.00418	CcSEcCtD
Almotriptan—Rash—Mechlorethamine—lymphatic system cancer	0.00128	0.00415	CcSEcCtD
Almotriptan—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00128	0.00415	CcSEcCtD
Almotriptan—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00128	0.00412	CcSEcCtD
Almotriptan—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00125	0.00403	CcSEcCtD
Almotriptan—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00125	0.00402	CcSEcCtD
Almotriptan—Myocardial infarction—Vincristine—lymphatic system cancer	0.00124	0.004	CcSEcCtD
Almotriptan—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00124	0.004	CcSEcCtD
Almotriptan—Feeling abnormal—Teniposide—lymphatic system cancer	0.00124	0.004	CcSEcCtD
Almotriptan—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00123	0.00397	CcSEcCtD
Almotriptan—Chills—Bleomycin—lymphatic system cancer	0.00122	0.00395	CcSEcCtD
Almotriptan—Bone disorder—Methotrexate—lymphatic system cancer	0.00121	0.00392	CcSEcCtD
Almotriptan—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00121	0.00392	CcSEcCtD
Almotriptan—Nausea—Mechlorethamine—lymphatic system cancer	0.00121	0.00391	CcSEcCtD
Almotriptan—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00121	0.0039	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.0012	0.00388	CcSEcCtD
Almotriptan—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.0012	0.00387	CcSEcCtD
Almotriptan—Body temperature increased—Teniposide—lymphatic system cancer	0.00119	0.00384	CcSEcCtD
Almotriptan—Abdominal pain—Teniposide—lymphatic system cancer	0.00119	0.00384	CcSEcCtD
Almotriptan—Erythema—Bleomycin—lymphatic system cancer	0.00119	0.00383	CcSEcCtD
Almotriptan—Paraesthesia—Fludarabine—lymphatic system cancer	0.00118	0.00383	CcSEcCtD
Almotriptan—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00118	0.00382	CcSEcCtD
Almotriptan—Dyspnoea—Fludarabine—lymphatic system cancer	0.00118	0.0038	CcSEcCtD
Almotriptan—Dyspepsia—Fludarabine—lymphatic system cancer	0.00116	0.00375	CcSEcCtD
Almotriptan—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00115	0.00373	CcSEcCtD
Almotriptan—Visual impairment—Carmustine—lymphatic system cancer	0.00115	0.0037	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00114	0.00368	CcSEcCtD
Almotriptan—Fatigue—Fludarabine—lymphatic system cancer	0.00114	0.00368	CcSEcCtD
Almotriptan—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00113	0.00365	CcSEcCtD
Almotriptan—Pain—Fludarabine—lymphatic system cancer	0.00113	0.00365	CcSEcCtD
Almotriptan—Eye disorder—Carmustine—lymphatic system cancer	0.00111	0.00359	CcSEcCtD
Almotriptan—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00111	0.00358	CcSEcCtD
Almotriptan—Hypersensitivity—Teniposide—lymphatic system cancer	0.00111	0.00357	CcSEcCtD
Almotriptan—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0011	0.00355	CcSEcCtD
Almotriptan—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.0011	0.00354	CcSEcCtD
Almotriptan—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00109	0.00351	CcSEcCtD
Almotriptan—Asthenia—Teniposide—lymphatic system cancer	0.00108	0.00348	CcSEcCtD
Almotriptan—Malaise—Bleomycin—lymphatic system cancer	0.00107	0.00345	CcSEcCtD
Almotriptan—Pruritus—Teniposide—lymphatic system cancer	0.00106	0.00343	CcSEcCtD
Almotriptan—Cardiac disorder—Vincristine—lymphatic system cancer	0.00105	0.0034	CcSEcCtD
Almotriptan—Body temperature increased—Fludarabine—lymphatic system cancer	0.00104	0.00337	CcSEcCtD
Almotriptan—Mental disorder—Carmustine—lymphatic system cancer	0.00104	0.00337	CcSEcCtD
Almotriptan—Erythema—Carmustine—lymphatic system cancer	0.00103	0.00334	CcSEcCtD
Almotriptan—Diarrhoea—Teniposide—lymphatic system cancer	0.00103	0.00332	CcSEcCtD
Almotriptan—Chest pain—Bleomycin—lymphatic system cancer	0.00101	0.00326	CcSEcCtD
Almotriptan—Myalgia—Bleomycin—lymphatic system cancer	0.00101	0.00326	CcSEcCtD
Almotriptan—Back pain—Carmustine—lymphatic system cancer	0.001	0.00323	CcSEcCtD
Almotriptan—Discomfort—Bleomycin—lymphatic system cancer	0.000997	0.00322	CcSEcCtD
Almotriptan—Mental disorder—Vincristine—lymphatic system cancer	0.000994	0.00321	CcSEcCtD
Almotriptan—Chills—Mitoxantrone—lymphatic system cancer	0.000991	0.0032	CcSEcCtD
Almotriptan—Confusional state—Bleomycin—lymphatic system cancer	0.000975	0.00315	CcSEcCtD
Almotriptan—Vision blurred—Carmustine—lymphatic system cancer	0.000975	0.00315	CcSEcCtD
Almotriptan—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000972	0.00314	CcSEcCtD
Almotriptan—Tremor—Carmustine—lymphatic system cancer	0.000969	0.00313	CcSEcCtD
Almotriptan—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000967	0.00313	CcSEcCtD
Almotriptan—Erythema—Mitoxantrone—lymphatic system cancer	0.000962	0.00311	CcSEcCtD
Almotriptan—Back pain—Vincristine—lymphatic system cancer	0.000955	0.00309	CcSEcCtD
Almotriptan—Vomiting—Teniposide—lymphatic system cancer	0.000954	0.00308	CcSEcCtD
Almotriptan—Agitation—Carmustine—lymphatic system cancer	0.000951	0.00307	CcSEcCtD
Almotriptan—Asthenia—Fludarabine—lymphatic system cancer	0.000947	0.00306	CcSEcCtD
Almotriptan—Rash—Teniposide—lymphatic system cancer	0.000946	0.00306	CcSEcCtD
Almotriptan—Dermatitis—Teniposide—lymphatic system cancer	0.000946	0.00306	CcSEcCtD
Almotriptan—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000942	0.00304	CcSEcCtD
Almotriptan—Headache—Teniposide—lymphatic system cancer	0.00094	0.00304	CcSEcCtD
Almotriptan—Pruritus—Fludarabine—lymphatic system cancer	0.000933	0.00302	CcSEcCtD
Almotriptan—Back pain—Mitoxantrone—lymphatic system cancer	0.00093	0.00301	CcSEcCtD
Almotriptan—Agitation—Vincristine—lymphatic system cancer	0.000908	0.00293	CcSEcCtD
Almotriptan—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000906	0.00293	CcSEcCtD
Almotriptan—Diarrhoea—Fludarabine—lymphatic system cancer	0.000903	0.00292	CcSEcCtD
Almotriptan—Convulsion—Carmustine—lymphatic system cancer	0.000896	0.0029	CcSEcCtD
Almotriptan—Hypertension—Carmustine—lymphatic system cancer	0.000893	0.00289	CcSEcCtD
Almotriptan—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000892	0.00288	CcSEcCtD
Almotriptan—Nausea—Teniposide—lymphatic system cancer	0.000892	0.00288	CcSEcCtD
Almotriptan—Vertigo—Vincristine—lymphatic system cancer	0.000887	0.00287	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000881	0.00285	CcSEcCtD
Almotriptan—Chest pain—Carmustine—lymphatic system cancer	0.000881	0.00285	CcSEcCtD
Almotriptan—Myalgia—Carmustine—lymphatic system cancer	0.000881	0.00285	CcSEcCtD
Almotriptan—Anxiety—Carmustine—lymphatic system cancer	0.000878	0.00284	CcSEcCtD
Almotriptan—Paraesthesia—Bleomycin—lymphatic system cancer	0.000869	0.00281	CcSEcCtD
Almotriptan—Malaise—Mitoxantrone—lymphatic system cancer	0.000867	0.0028	CcSEcCtD
Almotriptan—Dyspnoea—Bleomycin—lymphatic system cancer	0.000862	0.00279	CcSEcCtD
Almotriptan—Convulsion—Vincristine—lymphatic system cancer	0.000856	0.00277	CcSEcCtD
Almotriptan—Hypertension—Vincristine—lymphatic system cancer	0.000853	0.00276	CcSEcCtD
Almotriptan—Confusional state—Carmustine—lymphatic system cancer	0.000851	0.00275	CcSEcCtD
Almotriptan—Myalgia—Vincristine—lymphatic system cancer	0.000841	0.00272	CcSEcCtD
Almotriptan—Vomiting—Fludarabine—lymphatic system cancer	0.000839	0.00271	CcSEcCtD
Almotriptan—Convulsion—Mitoxantrone—lymphatic system cancer	0.000833	0.00269	CcSEcCtD
Almotriptan—Rash—Fludarabine—lymphatic system cancer	0.000832	0.00269	CcSEcCtD
Almotriptan—Dermatitis—Fludarabine—lymphatic system cancer	0.000831	0.00269	CcSEcCtD
Almotriptan—Hypertension—Mitoxantrone—lymphatic system cancer	0.00083	0.00268	CcSEcCtD
Almotriptan—Pain—Bleomycin—lymphatic system cancer	0.000827	0.00267	CcSEcCtD
Almotriptan—Headache—Fludarabine—lymphatic system cancer	0.000827	0.00267	CcSEcCtD
Almotriptan—Tachycardia—Carmustine—lymphatic system cancer	0.000824	0.00266	CcSEcCtD
Almotriptan—Chest pain—Mitoxantrone—lymphatic system cancer	0.000819	0.00265	CcSEcCtD
Almotriptan—Myalgia—Mitoxantrone—lymphatic system cancer	0.000819	0.00265	CcSEcCtD
Almotriptan—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000819	0.00265	CcSEcCtD
Almotriptan—Anxiety—Mitoxantrone—lymphatic system cancer	0.000816	0.00264	CcSEcCtD
Almotriptan—Discomfort—Mitoxantrone—lymphatic system cancer	0.000809	0.00261	CcSEcCtD
Almotriptan—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000806	0.00261	CcSEcCtD
Almotriptan—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000797	0.00258	CcSEcCtD
Almotriptan—Confusional state—Mitoxantrone—lymphatic system cancer	0.000792	0.00256	CcSEcCtD
Almotriptan—Nervous system disorder—Vincristine—lymphatic system cancer	0.00079	0.00255	CcSEcCtD
Almotriptan—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000785	0.00254	CcSEcCtD
Almotriptan—Nausea—Fludarabine—lymphatic system cancer	0.000784	0.00253	CcSEcCtD
Almotriptan—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000779	0.00252	CcSEcCtD
Almotriptan—Shock—Mitoxantrone—lymphatic system cancer	0.000772	0.0025	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000769	0.00249	CcSEcCtD
Almotriptan—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000766	0.00248	CcSEcCtD
Almotriptan—Body temperature increased—Bleomycin—lymphatic system cancer	0.000765	0.00247	CcSEcCtD
Almotriptan—Insomnia—Carmustine—lymphatic system cancer	0.000764	0.00247	CcSEcCtD
Almotriptan—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000762	0.00246	CcSEcCtD
Almotriptan—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000759	0.00245	CcSEcCtD
Almotriptan—Paraesthesia—Carmustine—lymphatic system cancer	0.000758	0.00245	CcSEcCtD
Almotriptan—Dyspnoea—Carmustine—lymphatic system cancer	0.000753	0.00243	CcSEcCtD
Almotriptan—Somnolence—Carmustine—lymphatic system cancer	0.000751	0.00243	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000734	0.00237	CcSEcCtD
Almotriptan—Insomnia—Vincristine—lymphatic system cancer	0.000729	0.00236	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000729	0.00236	CcSEcCtD
Almotriptan—Paraesthesia—Vincristine—lymphatic system cancer	0.000724	0.00234	CcSEcCtD
Almotriptan—Pain—Carmustine—lymphatic system cancer	0.000722	0.00233	CcSEcCtD
Almotriptan—Breast disorder—Methotrexate—lymphatic system cancer	0.000719	0.00232	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000715	0.00231	CcSEcCtD
Almotriptan—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000713	0.0023	CcSEcCtD
Almotriptan—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000705	0.00228	CcSEcCtD
Almotriptan—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.0007	0.00226	CcSEcCtD
Almotriptan—Somnolence—Mitoxantrone—lymphatic system cancer	0.000698	0.00226	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000696	0.00225	CcSEcCtD
Almotriptan—Feeling abnormal—Carmustine—lymphatic system cancer	0.000696	0.00225	CcSEcCtD
Almotriptan—Fatigue—Vincristine—lymphatic system cancer	0.000695	0.00225	CcSEcCtD
Almotriptan—Asthenia—Bleomycin—lymphatic system cancer	0.000694	0.00224	CcSEcCtD
Almotriptan—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000691	0.00223	CcSEcCtD
Almotriptan—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00069	0.00223	CcSEcCtD
Almotriptan—Pain—Vincristine—lymphatic system cancer	0.000689	0.00223	CcSEcCtD
Almotriptan—Pruritus—Bleomycin—lymphatic system cancer	0.000684	0.00221	CcSEcCtD
Almotriptan—Fatigue—Mitoxantrone—lymphatic system cancer	0.000677	0.00219	CcSEcCtD
Almotriptan—Pain—Mitoxantrone—lymphatic system cancer	0.000671	0.00217	CcSEcCtD
Almotriptan—Abdominal pain—Carmustine—lymphatic system cancer	0.000667	0.00216	CcSEcCtD
Almotriptan—Body temperature increased—Carmustine—lymphatic system cancer	0.000667	0.00216	CcSEcCtD
Almotriptan—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000659	0.00213	CcSEcCtD
Almotriptan—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000659	0.00213	CcSEcCtD
Almotriptan—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000647	0.00209	CcSEcCtD
Almotriptan—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000642	0.00207	CcSEcCtD
Almotriptan—Abdominal pain—Vincristine—lymphatic system cancer	0.000637	0.00206	CcSEcCtD
Almotriptan—Body temperature increased—Vincristine—lymphatic system cancer	0.000637	0.00206	CcSEcCtD
Almotriptan—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000628	0.00203	CcSEcCtD
Almotriptan—Hypersensitivity—Carmustine—lymphatic system cancer	0.000622	0.00201	CcSEcCtD
Almotriptan—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000621	0.00201	CcSEcCtD
Almotriptan—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000621	0.00201	CcSEcCtD
Almotriptan—Vomiting—Bleomycin—lymphatic system cancer	0.000615	0.00199	CcSEcCtD
Almotriptan—Rash—Bleomycin—lymphatic system cancer	0.00061	0.00197	CcSEcCtD
Almotriptan—Dermatitis—Bleomycin—lymphatic system cancer	0.000609	0.00197	CcSEcCtD
Almotriptan—Asthenia—Carmustine—lymphatic system cancer	0.000606	0.00196	CcSEcCtD
Almotriptan—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000596	0.00193	CcSEcCtD
Almotriptan—Hypersensitivity—Vincristine—lymphatic system cancer	0.000594	0.00192	CcSEcCtD
Almotriptan—Epistaxis—Methotrexate—lymphatic system cancer	0.000578	0.00187	CcSEcCtD
Almotriptan—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000578	0.00187	CcSEcCtD
Almotriptan—Asthenia—Vincristine—lymphatic system cancer	0.000578	0.00187	CcSEcCtD
Almotriptan—Diarrhoea—Carmustine—lymphatic system cancer	0.000578	0.00187	CcSEcCtD
Almotriptan—Nausea—Bleomycin—lymphatic system cancer	0.000575	0.00186	CcSEcCtD
Almotriptan—Asthenia—Mitoxantrone—lymphatic system cancer	0.000563	0.00182	CcSEcCtD
Almotriptan—Dizziness—Carmustine—lymphatic system cancer	0.000558	0.0018	CcSEcCtD
Almotriptan—Diarrhoea—Vincristine—lymphatic system cancer	0.000551	0.00178	CcSEcCtD
Almotriptan—Pharyngitis—Methotrexate—lymphatic system cancer	0.000546	0.00177	CcSEcCtD
Almotriptan—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000537	0.00174	CcSEcCtD
Almotriptan—Vomiting—Carmustine—lymphatic system cancer	0.000537	0.00174	CcSEcCtD
Almotriptan—Dizziness—Vincristine—lymphatic system cancer	0.000533	0.00172	CcSEcCtD
Almotriptan—Rash—Carmustine—lymphatic system cancer	0.000532	0.00172	CcSEcCtD
Almotriptan—Dermatitis—Carmustine—lymphatic system cancer	0.000532	0.00172	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—lymphatic system cancer	0.000531	0.00171	CcSEcCtD
Almotriptan—Headache—Carmustine—lymphatic system cancer	0.000529	0.00171	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—lymphatic system cancer	0.000514	0.00166	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—lymphatic system cancer	0.000513	0.00166	CcSEcCtD
Almotriptan—Vomiting—Vincristine—lymphatic system cancer	0.000512	0.00166	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000511	0.00165	CcSEcCtD
Almotriptan—Rash—Vincristine—lymphatic system cancer	0.000508	0.00164	CcSEcCtD
Almotriptan—Dermatitis—Vincristine—lymphatic system cancer	0.000508	0.00164	CcSEcCtD
Almotriptan—Headache—Vincristine—lymphatic system cancer	0.000505	0.00163	CcSEcCtD
Almotriptan—Nausea—Carmustine—lymphatic system cancer	0.000502	0.00162	CcSEcCtD
Almotriptan—Vomiting—Mitoxantrone—lymphatic system cancer	0.000499	0.00161	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—lymphatic system cancer	0.000497	0.00161	CcSEcCtD
Almotriptan—Rash—Mitoxantrone—lymphatic system cancer	0.000495	0.0016	CcSEcCtD
Almotriptan—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000494	0.0016	CcSEcCtD
Almotriptan—Chills—Methotrexate—lymphatic system cancer	0.000494	0.0016	CcSEcCtD
Almotriptan—Headache—Mitoxantrone—lymphatic system cancer	0.000492	0.00159	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—lymphatic system cancer	0.000482	0.00156	CcSEcCtD
Almotriptan—Erythema—Methotrexate—lymphatic system cancer	0.000479	0.00155	CcSEcCtD
Almotriptan—Nausea—Vincristine—lymphatic system cancer	0.000479	0.00155	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—lymphatic system cancer	0.000469	0.00152	CcSEcCtD
Almotriptan—Nausea—Mitoxantrone—lymphatic system cancer	0.000466	0.00151	CcSEcCtD
Almotriptan—Back pain—Methotrexate—lymphatic system cancer	0.000464	0.0015	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—lymphatic system cancer	0.000452	0.00146	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000445	0.00144	CcSEcCtD
Almotriptan—Malaise—Methotrexate—lymphatic system cancer	0.000432	0.0014	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—lymphatic system cancer	0.000431	0.00139	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—lymphatic system cancer	0.000415	0.00134	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—lymphatic system cancer	0.000408	0.00132	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—lymphatic system cancer	0.000408	0.00132	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—lymphatic system cancer	0.000408	0.00132	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000405	0.00131	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—lymphatic system cancer	0.000403	0.0013	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—lymphatic system cancer	0.000394	0.00127	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000391	0.00126	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000384	0.00124	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—lymphatic system cancer	0.00038	0.00123	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000378	0.00122	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000356	0.00115	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—lymphatic system cancer	0.000354	0.00114	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—lymphatic system cancer	0.000351	0.00114	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—lymphatic system cancer	0.000349	0.00113	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—lymphatic system cancer	0.000348	0.00112	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—lymphatic system cancer	0.000344	0.00111	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000338	0.00109	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—lymphatic system cancer	0.000337	0.00109	CcSEcCtD
Almotriptan—Pain—Methotrexate—lymphatic system cancer	0.000334	0.00108	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000322	0.00104	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00032	0.00103	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—lymphatic system cancer	0.000309	0.000999	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—lymphatic system cancer	0.000309	0.000999	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000288	0.000931	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—lymphatic system cancer	0.000281	0.000907	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—lymphatic system cancer	0.000277	0.000894	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—lymphatic system cancer	0.000268	0.000865	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—lymphatic system cancer	0.000259	0.000836	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—lymphatic system cancer	0.000249	0.000804	CcSEcCtD
Almotriptan—Rash—Methotrexate—lymphatic system cancer	0.000247	0.000797	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—lymphatic system cancer	0.000246	0.000796	CcSEcCtD
Almotriptan—Headache—Methotrexate—lymphatic system cancer	0.000245	0.000792	CcSEcCtD
Almotriptan—Nausea—Methotrexate—lymphatic system cancer	0.000232	0.000751	CcSEcCtD
